RSW Share Price Performance
RSW Community Fair Values
- UK£44.00FV34.0% undervalued intrinsic discount7.92%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative0users have followed this narrativeNew narrative
- AN
Consensus Narrative from 9 AnalystsNeuro And Additive Manufacturing Investments Will Boost Future Prospects
Key Takeaways Strong semiconductor market performance and aerospace investments are expected to boost Renishaw's revenue and future growth. Strategic focus on emerging markets and innovative technologies aims to increase market share and enhance profitability.UK£31.30FV7.2% undervalued intrinsic discount4.94%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative9users have followed this narrative4 days ago author updated this narrative - UK£23.80FV22.1% overvalued intrinsic discount4.96%Revenue growth p.a.0users have liked this narrative0users have commented on this narrative0users have followed this narrativeNew narrative
Recent RSW News & Updates
No updates
Renishaw plc Key Details
Last Reported Earnings
Dec 31, 2024
Next Reporting Earnings
Sep 03, 2025
- Earnings per share (EPS)
- 1.34
- Gross Margin
- 47.24%
- Net Profit Margin
- 13.90%
- Debt/Equity Ratio
- 0.4%
Renishaw plc Competitors
About RSW
- Founded
- 1973
- Employees
- 5256
- CEO
- WebsiteView website
Renishaw plc, an engineering and scientific technology company, designs, manufactures, distributes, sells, and services technological products and services, and analytical instruments and medical devices worldwide. The company offers precision measurement and process control products, such as co-ordinate measuring machine probes, software, retrofits, equator gauging systems, fixtures, machine calibration and optimization, machine tool probes, precision styli for metrology, and smart manufacturing data platform; and position and motion control products comprising interferometric laser, magnetic, and optical encoders. It also provides healthcare products, such as neuromate stereotactic robots, neuroinfuse drug delivery systems, neuroinspire surgical planning software, dixi medical's, and Raman spectrometers; and additive 3D printing manufacturing systems. It serves the aerospace, automotive, consumer electronics, medical and healthcare, heavy, machine builder, and precision manufacturing industries, as well as scientific, research, and analysis industries. The company was incorporated in 1973 and is headquartered in Wotton-under-Edge, the United Kingdom.
U.K. Market Performance
- 7 Days: -2.5%
- 3 Months: 17.0%
- 1 Year: 12.4%
- Year to Date: 12.2%
Over the last 7 days, the market has dropped 2.5%, driven by a loss of 2.3% in the Financials sector. In the last year, the market is actually up 12%. Looking forward, earnings are forecast to grow by 13% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading